HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.
Gurrin LC, Bertalli NA, Dalton GW, Osborne NJ, Constantine CC, McLaren CE, English DR, Gertig DM, Delatycki MB, Nicoll AJ, Southey MC, Hopper JL, Giles GG, Anderson GJ, Olynyk JK, Powell LW, Allen KJ; HealthIron Study Investigators.
Hepatology. 2009 Jul;50(1):94-101.PMID: 19554541 [PubMed - indexed for MEDLINE]Related articles